Literature DB >> 23211573

Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.

Roger Abs1, Anders F Mattsson, Maria Thunander, Johan Verhelst, Miklós I Góth, Patrick Wilton, Maria Kołtowska-Häggström, Anton Luger.   

Abstract

OBJECTIVE: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. DESIGN AND METHODS: Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.
RESULTS: PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.
CONCLUSIONS: GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23211573     DOI: 10.1530/EJE-12-0807

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

1.  Differential impact of selective GH deficiency and endogenous GH excess on insulin-mediated actions in muscle and liver of male mice.

Authors:  Jose Cordoba-Chacon; Manuel D Gahete; Owen P McGuinness; Rhonda D Kineman
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-30       Impact factor: 4.310

2.  Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study.

Authors:  V Gasco; L Roncoroni; M Zavattaro; C Bona; A Berton; E Ghigo; M Maccario; S Grottoli
Journal:  J Endocrinol Invest       Date:  2019-08-22       Impact factor: 4.256

3.  Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury.

Authors:  Stefania Giuliano; Serafina Talarico; Lucia Bruno; Francesco Beniamino Nicoletti; Claudio Ceccotti; Antonino Belfiore
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

Review 4.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

5.  Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group.

Authors:  Ah Reum Khang; Eu Jeong Ku; Ye An Kim; Eun Roh; Jae Hyun Bae; Tae Jung Oh; Sang Wan Kim; Chan Soo Shin; Seong Yeon Kim; Jung Hee Kim
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

6.  The visceral adiposity index is associated with insulin sensitivity and IGF-I levels in adults with growth hormone deficiency.

Authors:  Alessandro Ciresi; Stefano Radellini; Valentina Guarnotta; Carla Giordano
Journal:  Endocrine       Date:  2016-08-13       Impact factor: 3.633

7.  IGF-1 Levels are Inversely Associated With Metabolic Syndrome in Obstructive Sleep Apnea.

Authors:  Suelem Izumi; Fernando F Ribeiro-Filho; Gláucia Carneiro; Sônia M Togeiro; Sérgio Tufik; Maria T Zanella
Journal:  J Clin Sleep Med       Date:  2016-04-15       Impact factor: 4.062

8.  Long- but not short-term adult-onset, isolated GH deficiency in male mice leads to deterioration of β-cell function, which cannot be accounted for by changes in β-cell mass.

Authors:  Jose Cordoba-Chacon; Manuel D Gahete; Naveen K Pokala; David Geldermann; Maria Alba; Roberto Salvatori; Raul M Luque; Rhonda D Kineman
Journal:  Endocrinology       Date:  2013-12-16       Impact factor: 4.736

Review 9.  The Interaction of Insulin and Pituitary Hormone Syndromes.

Authors:  Marie Helene Schernthaner-Reiter; Peter Wolf; Greisa Vila; Anton Luger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

Review 10.  Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement.

Authors:  M Ahmid; C G Perry; S F Ahmed; M G Shaikh
Journal:  Endocr Connect       Date:  2016-04-29       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.